Skip to content

DNA Methylation-Based Liquid Biopsy for Metastatic Triple-Negative Breast Cancer (mTNBC)

mDETECT - A next-generation sequencing methylation-based blood test for detection and monitoring of TNBC

Published: 7th November 2017
DNA Methylation-Based Liquid Biopsy for Metastatic Triple-Negative Breast Cancer (mTNBC)
Please note, header image is purely illustrative. Source: LaCasadeGoethe, pixabay, CC0
IP Status
  • Patent application submitted
Seeking
  • Licensing
  • Development partner
  • Seeking investment